ESTROGEN STIMULATION OF GALANIN GENE-EXPRESSION AND GALANIN-LIKE IMMUNOREACTIVITY IN THE RAT AND ITS BLOCKADE BY THE ESTROGEN ANTAGONIST KEOXIFENE (LY156758)
Sm. Gabriel et al., ESTROGEN STIMULATION OF GALANIN GENE-EXPRESSION AND GALANIN-LIKE IMMUNOREACTIVITY IN THE RAT AND ITS BLOCKADE BY THE ESTROGEN ANTAGONIST KEOXIFENE (LY156758), Regulatory peptides, 45(3), 1993, pp. 407-419
Rat galanin (rGAL) gene expression is stimulated potently by 17beta-es
tradiol in the anterior pituitary. Neuroendocrine tissue extracts of w
ere purified by chromatography and analyzed for rGAL-like (-LI) immuno
reactivity. Greater than 90% of rGAL-LI eluted at the same position as
the synthetic rGAL standard in untreated anterior pituitary, median e
minence and neurointermediate lobe tissues. Additional immunoreactive
forms were detected in the hypothalamus, anterior pituitary and MtT/W
15 adenoma tissues, particularly after 17beta-estradiol treatment. We
examined rGAL and its encoding mRNA in the anterior pituitary of immat
ure female rats after the injection of pregnant mare serum gonadotropi
n (PMSG). One and two days after PMSG injection, serum 17beta-estradio
l increased 3-fold and 4-fold, respectively. This resulted in a surge
of endogenous gonadotropin 2 days after PMSG. At this time, rGAL-encod
ing mRNA was increased 40-fold over controls. Three days after PMSG, t
here was a 6-fold increase in anterior pituitary and a 41% increase in
plasma rGAL-LI concentrations. Plasma 17beta-estradiol one day after
injection of PMSG and the consequent anterior pituitary rGAL-LI concen
trations 2 days later were positively correlated. This stimulation of
rGAL and its encoding mRNA by PMSG was inhibited by treatment with the
estrogen antagonist keoxifene (LY156758).